跳至主要内容
临床试验/NCT00475267
NCT00475267已完成不适用

An Observational, Prospective Evaluation of the Trifecta Valve

Abbott Medical Devices10 个研究点 分布在 1 个国家目标入组 203 人开始时间: 2007年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
203
试验地点
10
主要终点
Characterize the hemodynamic performance of the valve.

研究概览

简要总结

The purpose of this study is to confirm the clinical safety and effectiveness of the Trifecta valve.

详细描述

The clinical investigation is a multi-center, multi-country, prospective, non-randomized, observational study designed to evaluate the safety and effectiveness of the Trifecta valve.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Requires aortic valve replacement (heart surgery such as bypass is allowed at the same time).
  • Legal age.
  • Signed informed consent prior to surgery.
  • Willing to complete all follow-up requirements.

排除标准

  • Pregnant or nursing women.
  • Have already had a valve replaced other than the aortic valve.
  • Needs another valve replaced.
  • Cannot return for required follow-up visits.
  • Have active endocarditis.
  • Acute preoperative neurological event (such as a stroke).
  • Renal dialysis.
  • History of substance abuse within one year, or a prison inmate.
  • Participating in another study.
  • Life expectancy less than two years.

结局指标

主要结局

Characterize the hemodynamic performance of the valve.

时间窗: At required follow-up intervals

Characterize patient NYHA functional classification status.

时间窗: At required follow-up intervals

Establish adverse event rates.

时间窗: Ongoing

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Aortic Valve Replacement With Trifecta(TM) | 临床试验